AsiaMedic to acquire LuyeEllium Healthcare for S$42.2 million
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
ASIAMEDIC has entered into a conditional sale and purchase agreement with the shareholders of LuyeEllium Healthcare to acquire the company for S$42.2 million.
LuyeEllium provides hospital management services to hospitals in South Korea and China.
The consideration will be fulfilled via the issuance of 527.1 million new shares, at the issue price of eight Singapore cents per share.
Upon completion of the proposed acquisition, it will be a wholly owned subsidiary of the AsiaMedic.
AsiaMedic will be appointing an independent valuer to prepare a valuation report on LuyeEllium.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025
